Unique biological function of cathepsin L in secretory vesicles for biosynthesis of neuropeptides

Neuropeptides

Volumn 44, Issue 6, 2010, Pages 457-466

  Funkelstein, Lydiane ^a   Beinfeld, Margery ^b   Minokadeh, Ardalan ^a,c   Zadina, James ^c   Hook, Vivian ^a,d  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TULANE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cathepsin L; Cell cell communication; Cholecystokinin; Dynorphin; Endocrine; Enkephalin; Neuropeptides; Neurotransmission; NPY; Proprotein convertase; Proteases; Secretory vesicles

Indexed keywords

ALPHA INTERMEDIN; BETA ENDORPHIN; CATESTATIN; CATHEPSIN L; CHOLECYSTOKININ; CORTICOTROPIN; DYNORPHIN; ENKEPHALIN; NEUROPEPTIDE; NEUROPEPTIDE Y; PROENKEPHALIN; PROPROTEIN CONVERTASE 1; PROPROTEIN CONVERTASE 2; PROTEINASE;

CELL COMMUNICATION; GENE EXPRESSION; GENE INACTIVATION; IN VIVO STUDY; LYSOSOME; MASS SPECTROMETRY; NEUROENDOCRINE SYSTEM; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SECRETORY VESICLE;

AMINO ACID SEQUENCE; ANIMALS; CATHEPSIN L; ENKEPHALINS; GENE KNOCKDOWN TECHNIQUES; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; NEUROPEPTIDES; PROTEIN PRECURSORS; SECRETORY VESICLES;

MUS;

EID: 78349308399     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2010.08.003     Document Type: Review

References (59)

1. Akil H., Owens C., Gutstein H., Taylor L., Currran E., Watson S. Endogenous opioids: overview and current issues. Drug Alcohol Depend. 1998, 51:127-140.
2. Ansorge S., Kirschke H., Friedrich K. Conversion of proinsulin into insulin by cathepsins B and L from rat liver lysosomes. Acta Biol. Med. Ger. 1977, 36:1723-1727.
3. Azaryan A.V., Hook V.Y.H. Unique cleavage specificity of 'prohormone thiol protease' related to proenkephalin processing. FEBS Lett. 1994, 341:197-202.
4. Basak A., Koch P., Dupelle M., Fricker L.D., Devi L.A., Chrétien M., Seidah N.G. Inhibitory specificity and potency of proSAAS-derived peptides toward proprotein convertase 1. J. Biol. Chem. 2001, 276:32720-32728.
5. Bassi D.E., Fu J., Lopez de Cicco R., Klein-Szanto A.J. Proprotein convertases: " master switches" in the regulation of tumor growth and progression. Mol. Carcinog. 2005, 44:151-161.
6. Beinfeld M.C., Blum A., Vishnuvardhan D., Fanous S., Marchand J.E. Cholecystokinin levels in prohormone convertase 2 knock-out mouse brain regions reveal a complex phenotype of region-specific alterations. J. Biol. Chem. 2005, 280:38410-38415.
7. Beinfeld M.C., Funkelstein L., Foulon T., Cadel S., Kitagawa K., Toneff T., Reinheckel T., Peters C., Hook V.Y.H. Cathepsin L plays a major role in cholecystokinin production in mouse brain and in pituitary AtT-20 cells: protease gene knockout and inhibitor studies. Peptides 2009, 30:1882-1991.
8. Biswas N., Rodriquez-Flores J.L., Courel M., Gayen J.R., Vaingankar S.M., Mahata M., Torpey J.W., Taupenot L., O'Connor D.T., Mahata S.K. Cathepsin L colocalizes with chromogranin A in chromaffin vesicles to generate active peptides. Endocrinology 2009, 150:3547-3557.
9. Cain B.M., Connolly K., Blum A.C., Vishnuvardhan D., Marchand J.E., Zhu X., Steiner D.F., Beinfeld M.C. Genetic inactivation of prohormone convertase (PC1) causes a reduction in cholecystokinin (CCK) levels in the hippocampus, amygdala, pons and medulla in mouse brain that correlates with the degree of colocdalization of PC1 and CCk mRNA in these structures in rat brain. J. Neurochem. 2004, 89:307-313.
10. Collette J., Bocock J.P., Ahn K., Chapman R.L., Godbold G., Yeyeodu S., Erickson A.H. Biosynthesis and alternate targeting of the lysosomal cysteine protease cathepsin L. Int. Rev. Cytol. 2004, 241:1-51.
11. Cravatt B.F., Wright A.R., Kozarich J.W. Activity-based protein profiling: from enzyme chemistry to proteomic chemistry. Annu. Rev. Biochem. 2008, 77:383-414.
12. Duncan E.M., Muratore-Schroeder T.L., Cook R.G., Garcia B.A., Shabanowitz J., Hunt D.F., Allis C.D. Cathepsin L proteolytically processes histone H3 during mouse embryonic stem cell differentiation. Cell 2008, 135:284-294.
13. Fortenberry Y., Liu J., Lindberg I. The role of the 7B2 CT peptide in the inhibition of prohormone convertase 2 in endocrine cell lines. J. Neurochem. 1999, 73:994-1003.
14. Fricker L.D. Carboxypeptidase E. Annu. Rev. Physiol. 1988, 50:309-321.
15. Fukuda M. Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. J. Biol. Chem. 1991, 266:21327-21330.
16. Frohman L.A. Diseases of the anterior pituitary. Endocrinology and Metabolism 1995, 293-297. McGraw-Hill Inc., Health Professions Division, New York. third ed. P. Felig, J.D. Baxter, L.A. Frohman (Eds.).
17. Fugere M., Day R. Cutting back on pro-protein convertases: the latest approaches to pharmacological inhibition. Trends Pharmacol. Sci. 2005, 26:294-301.
18. Funkelstein L., Toneff T., Hwang S.R., Reinheckel T., Peters C., Hook V.Y.H. Cathepsin L participates in the production of neuropeptide Y in secretory vesicles, demonstrated by protease gene knockout and expression. J. Neurochem. 2008, 106:384-391.
19. Funkelstein L., Toneff T., Hwang S.R., Beuschlein F., Lichtenauer U.D., Reinheckel T., Peters C., Hook V.Y.H. Major role of cathepsin L for producing the peptide hormones ACTH, β-endorphin, and α-MSH, illustrated by protease gene knockout and expression. J. Biol. Chem. 2008, 83:35652-35659.
20. Gehlert D.R. Role of hypothalamic neuropeptide Y in feeding and obesity. Neuropeptides 1999, 33:329-338.
21. Hiwasa T., Sakiyama S. Nuclear localization of procathepsin L/MEP in ras-transformed mouse fibroblasts. Cancer Lett. 1996, 99:87-91.
22. Hook V.Y.H., Funkelstein L., Lu D., Bark S., Wegrzyn J., Hwang S.R. Proteases for processing proneuropeptides into peptide neurotransmitters and hormones. Annu. Rev. Pharmacol. Toxicol. 2008, 48:393-423.
23. Hook V., Funkelstein L., Toneff T., Mosier C., Hwang S.R. Human pituitary contains dual cathepsin L and prohormone convertase processing pathway components involved in converting POMC into the peptide hormones ACTH, alpha-MSH, and beta-endorphin. Endocrine 2009, 35:429-437.
24. Hook V.Y.H., Sei C., Yasothornsrikul S., Toneff T., Kang Y.-H., Efthimiopoulos S., Robakis N.K., Van Nostrand W. The kunitz protease inhibitor form of the amyloid precursor protein (KPI/APP) inhibits the proneuropeptide processing enzyme prohormone thiol protease (PTP). Colocalization of KPI/APP and PTP in secretory vesicles. J. Biol. Chem. 1999, 274:3165-3172.
25. Hook V.Y.H., Yasothornsrikul S. Carboxypeptidase and aminopeptidase proteases in pro-neuropeptide processing. Proteolytic and Cellular Mechanisms in Prohormone and Proprotein Processing 1998, 121-140. Landes Bioscience Publishers, Austin, Texas. V.Y.H. Hook (Ed.).
26. Hwang S.R., Garza C., Mosier C., Toneff T., Wunderlich E., Goldsmith P., Hook V.Y.H. Cathepsin L expression is directed to secretory vesicles for enkephalin neuropeptide biosynthesis and secretion. J. Biol. Chem. 2007, 282:9556-9563.
27. Hwang S.R., O'Neill A., Bark S., Foulon T., Hook V.Y.H. Secretory vesicle aminopeptidase B related to neuropeptide processing: molecular identification and subcellular localization to enkephalin- and NPY-containing chromaffin granules. J. Neurochem. 2007, 100:1340-1350.
28. Hwang S.R., Stoka V., Turk V., Hook V.Y.H. The novel bovine serpin endopin 2C demonstrates selective inhibition of the cysteine protease cathepsin L compared to the serine protease elastase, in cross-class inhibition. Biochemistry 2005, 44:7757-7767.
29. Ishidoh K., Kominami E. Processing and activation of lysosomal proteinases. Biol. Chem. 2002, 383:1827-1831.
30. Law P.Y., Wong Y.H., Loh H.H. Molecular mechanisms and regulation of opioid receptor signaling. Annu. Rev. Pharmacol. Toxicol. 2000, 40:389-430.
31. Leonardi A., Turk B., Turk V. Inhibition of cathepsins L and S by stefins and cystatins. Biol. Chem. Hoppe Seyler 1996, 377:319-321.
32. Mahata S.K., Mahata M., Fung M.M., O'Connor D.T. Catestatin: a multifunctional peptide from chromogranin A. Regul. Pept. 2010, 162:33-43.
33. Miller R., Aaron W., Toneff T., Vishnuvardhan D., Beinfeld M., Hook V.Y.H. Obliteration of α-melanocyte-stimulating hormone derived from POMC in pituitary and brains of PC2-deficient mice. J. Neurochem. 2003, 86:556-563.
34. Miller R., Toneff T., Vishnuvardhan D., Beinfeld M., Hook V.Y.H. Selective roles for the PC2 processing enzyme in the regulation of peptide neurotransmitter levels in brain and peripheral neuroendocrine tissues of PC2 deficient mice. Neuropeptides 2003, 37:140-148.
35. Minokadeh A., Funklestein L., Toneff T., Hwang S.R., Reinheckel T., Peters C., Zadina J., Hook V.Y.H. Cathepsin L participates in dynorphin neuropeptide production in brain cortex, illustrated by protease gene knockout and expression. Mol. Cell. Neurosci. 2010, 43:98-107.
36. Pan H., Nanno D., Che F.Y., Zhu X., Salton S.R., Steiner D.F., Fricker L.D., Devi L.A. Neuropeptide processing profiles in mice lacking prohormone convertase-1. Biochemistry 2005, 44:4939-4948.
37. Rehfeld J.F., Bundgaard J.R., Hannibal J., Zhu X., Norrbom C., Steiner D.F., Friis-Hansen L. The cell-specific pattern of cholecystokinin peptides in endocrine cells versus neurons is governed by the expression of prohormone convertases 1/3, 2, and 5/6. Endocrinology 2008, 149:1600-1608.
38. Ryvnyak V.V., Ryvnyak E.I., Tudos R.V. Electron histochemical localization of cathepsin L in the liver. Bull. Exp. Biol. Med. 2004, 137:90-91.
39. Scamuffa N., Calvo F., Chretien M., Seidah N.G., Khatib A.M. Proprotein convertases: lessons from knockouts. FASEB J. 2006, 20:1954-1963.
40. Seidah N.G., Khatib A.M., Prat A. The proprotein convertases and their implication in sterol and/or lipid metabolism. Biol. Chem. 2006, 387:871-877.
41. Seidah N.G., Prat A. Precursor convertases in the secretory pathway, cytosol and extracellular milieu. Essays Biochem. 2002, 38:79-94.
42. Shippenberg T.S., Zapata A., Chefer V.I. Dynorphin and the pathophysiology of drug addiction. Pharmacol. Ther. 2007, 116:306-321.
43. Snyder S.H., Pasternak G.W. Historical review: opioid receptors. Trends Pharmacol. Sci. 2003, 24:198-205.
44. Stawowy P., Fleck E. Proprotein convertases furin and PC5: targeting atherosclerosis and restenosis at multiple levels. J. Mol. Med. 2005, 83:865-875.
45. Steiner D.F. The proprotein convertases. Curr. Opin. Chem. Biol. 1998, 2:31-39.
46. Steiner R.A., Hohmann J.G., Holmes A., Wrenn C.C., Cadd G., Jureus A., Clifton D.K., Luo M., Gutshall M., Ma S.Y., Mufson E.J., Crawley J.N. Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 2001, 98:4184-4189.
47. Sullivan S., Tosetto M., Kevans D., Coss A., Wang L., O'Donoghue D., Hyland J., Sheahan K., Mulcahy H., O'Sullivan J. Localization of nuclear cathepsin L and its association with disease progression and poor outcome in colorectal cancer. Int. J. Cancer 2009, 125:54-61.
48. Thomas G. Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nature Rev. 2002, 3:753-766.
49. Wardman J.H., Zhang X., Gagnon S., Castro L.M., Zhu X., Steiner D.F., Day R., Fricker L.D. Analysis of peptides in prohormone convertase 1/3 null mouse brain using quantitative peptidomics. J. Neurochem. 2010, 114:215-225.
50. Vaingankar S.M., Li Y., Biswas N., Gayen J., Choksi S., Rao F., Ziegler M.G., Mahata S.K., O'Connor D.T. Effects of chromogranin A deficiency and excess in vivo: biphasic blood pressure and catecholamine responses. J. Hypertens. 2010, 28:817-825.
51. Waguri S., Sato N., Watanabe T., Ishidoh K., Kominami E., Sato K., Uchiyama Y. Cysteine proteinases in GH4C1 cells, a rat pituitary tumor cell line, are secreted by the constitutive and regulated secretory pathways. Eur. J. Cell. Biol. 1995, 67:308-318.
52. Walker P., Grouzmann E., Burnier M., Waeber B. The role of neuropeptide Y in cardiovascular regulation. TIPS 1991, 12:111-115.
53. Wang Z., Gardell L.W., Ossipov M.H., Vanderah T.W., Brennan M.B., Hochgeschwender U., Hruby V.J., Malan T.P., Lai J., Porreca F. Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J. Neurosci. 2001, 21:1779-1786.
54. Wieland H.A., Hamilton B.S., Krist B., Doods H.N. The role of NPY in metabolic homeostasis: implications for obesity therapy. Expert Opin. Investig. Drugs 2000, 9:1327-1346.
55. Yasothornsrikul S., Aaron W., Toneff T., Hook V.Y.H. Evidence for the proenkephalin processing enzyme prohormone thiol protease (PTP) as a multicatalytic cysteine protease complex: activation by glutathione localized to secretory vesicles. Biochemistry 1999, 38:7421-7430.
56. Yasothornsrikul S., Greenbaum D., Medzihradszky K.F., Toneff T., Bundey R., Miller R., Schilling B., Petermann I., Dehnert J., Logvinova A., Goldsmith P., Neveu J.M., Lane W.S., Gibson B., Reinheckel T., Peters C., Bogyo M., Hook V.Y.H. Cathepsin L in secretory vesicles functions as a prohormone-processing enzyme for production of the enkephalin peptide neurotransmitter. Proc. Natl. Acad. Sci. USA 2003, 100:9590-9595.
57. Yasothornsrikul S., Toneff T., Hwang S.R., Hook V.Y.H. Arginine and lysine aminopeptidase activities in chromaffin granules of bovine adrenal medulla: relevance to prohormone processing. J. Neurochem. 1998, 70:153-163.
58. Yokota S., Nishimura Y., Kato K. Localization of cathepsin L in rat kidney revealed by immunoenzyme and immunogold techniques. Histochemistry 1988, 90:277-283.
59. Zhang X., Panm H., Peng B., Steiner D.F., Pintar J.E., Fricker L.D. Neuropeptidomic analysis establishes a major role for prohormone convertase-2 in neuropeptide biosynthesis. J. Neurochem. 2010, 112:168-1179.